MDMA-assisted therapy for adolescents with treatment-resistant PTSD
Post-traumatic stress disorder (PTSD) can happen after very frightening or distressing events. It can cause upsetting memories, nightmares, and severe anxiety. Sometimes, standard treatments like regular talking therapy or everyday medicines do not bring enough relief. This is known as treatment-resistant PTSD. This study looks at a new approach for young people. It combines specialized talking therapy with carefully measured doses of a medicine called MDMA. The medicine is given in a calm, safe clinic with trained therapists to help participants process difficult memories without feeling overwhelmed. The main aim of this study is to find out if teenagers can comfortably complete the full programme of three therapy sessions. Doctors will closely track safety, side effects, and changes in trauma symptoms, anxiety, and everyday wellbeing to see if this treatment could offer hope for the future.
At a glance
What is this study about?
When young people experience traumatic events, the emotional impact can linger for months or years. Post-traumatic stress disorder (PTSD) can make everyday life feel exhausting, causing sleep problems, panic, and unwanted flashbacks. While many adolescents recover with standard NHS treatments, some find that their symptoms do not get better. This study is exploring a new treatment option for those who have not found relief through standard care.
The trial tests 'MDMA-assisted therapy'. MDMA is a medicine that alters brain chemistry to temporarily reduce fear and defensiveness while increasing feelings of trust and calm. In this study, medical-grade MDMA is given only a few times inside a clinic, alongside intensive support from trained therapists. The goal is to help the young person talk through painful memories that might otherwise feel too frightening to face.
Because this is an early-stage study, researchers primarily want to see if the programme is feasible and safe. They will track whether participants can complete all three guided sessions and attend follow-up meetings. They will also look closely at whether the treatment helps reduce PTSD symptoms, eases feelings of depression and anxiety, and improves overall quality of life.
Key takeaways
- The study tests whether MDMA combined with talking therapy is safe and manageable for teenagers with PTSD.
- It is aimed at young people whose trauma symptoms have not improved with usual treatments.
- Participants take medical-grade MDMA across three supervised clinic sessions with therapists present throughout.
- The research team will closely monitor changes in PTSD, anxiety, mood, and general wellbeing.
- Taking part is completely voluntary, and you can withdraw at any point without losing standard NHS support.
Who may be eligible?
This trial is designed for adolescents and young people who have a confirmed diagnosis of post-traumatic stress disorder (PTSD). Because it focuses on 'treatment-resistant' PTSD, participants will usually be young people who have already tried standard therapies or medications without feeling much better.
Both boys and girls can take part. However, participants must be well enough medically to receive the study drug. For example, people with certain heart problems, high blood pressure, or specific mental health conditions may not be able to join, as MDMA can temporarily raise heart rate and blood pressure.
Because MDMA can interact with other prescription medicines—particularly certain antidepressants—participants may need to discuss their current medications with the research team. A parent or legal guardian will also need to be involved to give permission for anyone under the age of 18.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am an adolescent or teenager diagnosed with PTSD.
- My PTSD symptoms have not fully improved after trying standard therapies or medicines.
- I am willing and able to attend all clinic visits, therapy days, and check-ups.
- I do not have major heart problems or uncontrolled high blood pressure.
- A parent or guardian is willing to support my participation if I am under 18.
What does participation involve?
Taking part in this study involves several stages over a few months. First, participants have preparation visits with two therapists to build trust and learn what to expect. Next, they take part in three full-day therapy sessions spaced a few weeks apart, where they take the study medicine in a quiet, comfortable clinic room with therapists present the entire time. After each medicine session, there are 'integration' talking sessions to help make sense of the experience. Researchers will check in regularly using simple questionnaires to track symptoms, mood, and safety. Total participation typically lasts several months.
Potential risks and benefits
Locations (1)
- —UnverifiedNetherlands
Common questions
Is the study medicine the same as the street drug ecstasy?
While ecstasy often contains MDMA, street drugs are illegal, uncontrolled, and frequently mixed with dangerous chemicals. This study uses pure, laboratory-tested, medical-grade MDMA given in very specific, safe doses under strict medical supervision.
Can taking part cause an addiction to MDMA?
In clinical studies, MDMA is only given two or three times under direct supervision, with no medicine taken home. Evidence from clinical research shows that this controlled medical use carries a very low risk of addiction.
Will parents or guardians be involved?
Yes. For adolescents, parents or legal guardians are closely involved in the consent process and are kept informed about the schedule and practical support needed throughout the trial.
What happens if the therapy feels too upsetting?
Trained therapists stay in the room for the entire session to offer continuous support, guide relaxation exercises, and ensure the participant feels safe and supported at all times.
Does taking part cost anything?
No, clinical trial treatments, assessments, and study-related care are provided at no cost, and travel expenses are often covered.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.